AI hype takes a hit—For most businesses, the revolutionary tool falls short

Screenshot 2025-12-18 at 2.06.21 PM

Some disillusionment was inevitable. When OpenAI released a free web app called ChatGPT in late 2022, it changed the course of an entire industry—and several world economies. … We were enchanted, and we expected more.

With nonstop one-upmanship, AI companies have presented each new product drop as a major breakthrough, reinforcing a widespread faith that this technology would just keep getting better.

[T]he heads of the top AI companies made promises they couldn’t keep. They told us that generative AI would replace the white-collar workforce, bring about an age of abundance, make scientific discoveries, and help find new cures for disease. 

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

That’s when the shine started to come off. Though the technology may have been billed as a universal multitool that could revamp outdated business processes and cut costs, a number of studies published this year suggest that firms are failing to make the AI pixie dust work its magic. 

This hype correction was long overdue. But know that AI isn’t going anywhere. We don’t even fully understand what we’ve built so far, let alone what’s coming next.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The Orange Bowl without oranges: Can CRISPR save Florida citrus?
ChatGPT-Image-May-1-2026-11_42_59-AM-2
Viewpoint: NAD is the wellness grifters latest evidence-lite longevity fad. At least the mice are impressed.
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
global warming
‘Implausible’: Top climate scientists reject worst-case scenario—soaring temperatures and fast-rising sea levels
vax-misinformation-main
Facts & Fallacies Podcast: Limit free speech to blunt social media misinfo?
ChatGPT Image May 26, 2026, 12_06_53 PM
Fake Ebola cure promoters already cashing in as disinformation videos flood social media
ChatGPT Image May 24, 2026, 03_16_36 PM
Here come the biohackers' Enhanced Games—The Olympics for athletes doping up on steroids, hormones and peptides. What’s wrong with that?
Screenshot 2026-05-22 at 11.31
‘Realistic and durable’: EPA proposes loosening restrictions on some PFAS ‘forever chemicals.’
Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
Screenshot-2026-05-21-at-12.15.17-PM
UK gene-editing milestone: Livestock barley that increases ruminant value and reduces methane emissions is first-approved CRISPR crop
Screenshot-2026-05-22-at-11.59.38-AM
Is surrogacy modern-day slavery? What to know about Florida Republican effort to pass severe restrictions.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.